Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tailored Drug Titration Using Artificial Intelligence
Sponsor: Optima Integrated Health
Summary
The purpose of the ARTERY Outcomes study is to compare optima-for-blood pressure (optima4BP), a clinical decision support system for hypertension (HTN) treatment optimization to standard of care in patients with essential HTN.
Official title: ARTERY Outcomes: Tailored Drug Titration Through Artificial Intelligence - an Interventional Study
Key Details
Gender
All
Age Range
21 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
165
Start Date
2020-02-18
Completion Date
2023-06-27
Last Updated
2026-07-20
Healthy Volunteers
No
Conditions
Interventions
optima4BP
optima4BP establishes a "no gaps" computational framework in determining the most effective treatment change that can optimize a patient's HTN management towards BP Target. All possible drug combination options available through the 16 anti-HTN drug classes and subclasses are quantitatively evaluated in the context of 5 actions: add a drug, remove a drug, replace a drug, increase a drug dose, and decrease a drug dose. The pharmacological intervention efficacy ranking is computed and the highest ranked treatment recommendation is selected for consideration by the treating physician.
Locations (1)
University of California San Francisco
San Francisco, California, United States